BTP-0611

N/A

Report date: 2025/03/26 20:01:25

Base Information

Drug NameBTP-0611
Drug Alias Name伐布雷定缓释制剂BTP-0611BTP0611
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHyperpolarization-activated cyclic nucleotide-gated channel blockers
TargetsHyperpolarization-activated cyclic nucleotide-gated channel
Therapy Area/IndicationsHeart FailureArrhythmia, Sinus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesJiangsu Nuo BHP New Drug Research and Development Co LtdBeijing Baiao Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Nuo BHP New Drug Research and Development Co LtdBeijing Baiao Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsHeart FailureArrhythmia, Sinus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A